BCMA x CD3 T-cell engager in a patient with penta-refractory multiple myeloma and HIV: a clinical and immunological report

被引：0
|
作者：
Cords, Leon [1 ]
Schaefers, Christoph [2 ]
Kamili, Abdulaziz [2 ]
Hoffmann, Christian [3 ,4 ]
Cichutek, Sophia [2 ]
Haag, Friedrich [5 ]
Polywka, Susanne [6 ]
Bokemeyer, Carsten [2 ]
Leypoldt, Lisa [2 ]
Alsdorf, Winfried [2 ]
zur Wiesch, Julian Schulze [1 ,7 ]
Weisel, Katja C. [2 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Infect Dis Unit, Hamburg, Germany
[2] Univ Med Ctr Hamburg Eppendorf, Dept Hematol Oncol & Bone Marrow Transplantat, Sect Pneumol, Hamburg, Germany
[3] ICH Study Ctr, Hamburg, Germany
[4] Univ Hosp Schleswig Holstein, Dept Internal Med 2, Campus Kiel, Kiel, Germany
[5] Univ Med Ctr Hamburg Eppendorf, Inst Immunol, Hamburg, Germany
[6] Univ Med Ctr Hamburg Eppendorf, Inst Med Microbiol Virol & Hyg, Hamburg, Germany
[7] German Ctr Infect Res DZIF, Partner Site Hamburg Lubeck Borstel Riems, Hamburg, Germany
来源：
HAEMATOLOGICA | 2024年 / 109卷 / 09期
基金：
欧盟地平线“2020”;
关键词：
D O I：
10.3324/haematol.2023.284917
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3071 / 3077
页数：7
相关论文
共 50 条
  • [1] Preclinical characterization of ISB 1342, a CD38 x CD3 T-cell engager for relapsed/refractory multiple myeloma
    Pouleau, Blandine
    Estoppey, Carole
    Suere, Perrine
    Nallet, Emilie
    Laurendon, Amelie
    Monney, Thierry
    Ferreira, Daniela Pais
    Drake, Adam
    Carretero-Iglesia, Laura
    Macoin, Julie
    Berret, Jeremy
    Pihlgren, Maria
    Doucey, Marie-Agnes
    Gudi, Girish S.
    Menon, Vinu
    Udupa, Venkatesha
    Maiti, Abhishek
    Borthakur, Gautam
    Srivastava, Ankita
    Blein, Stanislas
    Mbow, M. Lamine
    Matthes, Thomas
    Kaya, Zeynep
    Edwards, Claire M.
    Edwards, James R.
    Menoret, Emmanuelle
    Kervoelen, Charlotte
    Pellat-Deceunynck, Catherine
    Moreau, Philippe
    Zhukovsky, Eugene
    Perro, Mario
    Chimen, Myriam
    BLOOD, 2023, 142 (03) : 260 - 273
  • [2] A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo
    S Hipp
    Y-T Tai
    D Blanset
    P Deegen
    J Wahl
    O Thomas
    B Rattel
    P J Adam
    K C Anderson
    M Friedrich
    Leukemia, 2017, 31 : 1743 - 1751
  • [3] A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo
    Hipp, S.
    Tai, Y-T
    Blanset, D.
    Deegen, P.
    Wahl, J.
    Thomas, O.
    Rattel, B.
    Adam, P. J.
    Anderson, K. C.
    Friedrich, M.
    LEUKEMIA, 2017, 31 (08) : 1743 - 1751
  • [4] Erratum: A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo
    S Hipp
    Y-T Tai
    D Blanset
    P Deegen
    J Wahl
    O Thomas
    B Rattel
    P J Adam
    K C Anderson
    M Friedrich
    Leukemia, 2017, 31 : 2278 - 2278
  • [5] A Novel CD3/BCMA Bispecific T-cell Redirecting Antibody for the Treatment of Multiple Myeloma
    Xiong, Mengshang
    Liu, Ruoqi
    Lei, Xiaomin
    Fan, Dongmei
    Lin, Fangzhen
    Hao, Wei
    Yuan, Xiangfei
    Yang, Yuanyuan
    Zhang, Xiaolong
    Ye, Zhou
    Lu, Yang
    Zhang, Yanjun
    Wang, Jianxiang
    Xiong, Dongsheng
    JOURNAL OF IMMUNOTHERAPY, 2022, 45 (02) : 78 - 88
  • [6] Nivolumab-Based Salvage Therapy to Restore T Cell Fitness in Penta-Refractory Multiple Myeloma with Relapse to Anti-BCMA CAR T Cell Therapy
    Waldschmidt, Johannes M.
    Arora, Sankalp
    Vijaykumar, Tushara
    Sotudeh, Noori
    Anand, Praveen
    Stuart, Hannah
    Frede, Julia
    Campbell, Tim
    Kaiser, Shari M.
    Lamba, Manisha
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    Yee, Andrew J.
    Knoechel, Birgit
    Lohr, Jens G.
    Raje, Noopur
    BLOOD, 2022, 140 : 9925 - 9926
  • [7] A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo (vol 31, pg 1743, 2017)
    Hipp, S.
    Tai, Y-T
    Blanset, D.
    Deegen, P.
    Wahl, J.
    Thomas, O.
    Rattel, B.
    Adam, P. J.
    Anderson, K. C.
    Friedrich, M.
    LEUKEMIA, 2017, 31 (10) : 2278 - 2278
  • [8] The Biodistribution of a CD3 and EpCAM Bispecific T-Cell Engager Is Driven by the CD3 Arm
    Suurs, Frans, V
    Lorenczewski, Grit
    Stienen, Sabine
    Friedrich, Matthias
    de Vries, Elisabeth G. E.
    de Groot, Derk Jan A.
    Lub-de Hooge, Marjolijn N.
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61 (11) : 1594 - 1601
  • [9] Local Activator and T Cell Engager (αBCMA x αPD-L1 x αCD3) with Enhanced Tumor Killing and Minimal Cytokine Release for the Treatment of Multiple Myeloma
    Vrohlings, Melissa
    Jungmichel, Stephanie
    Mueller, Jan
    Senn, David
    Schleier, Thomas
    Scheifele, Fabian
    Wendelspiess, Severin
    Leisner, Christian
    Krauth, Maria-Theresa
    Jaeger, Ulrich
    Borras, Leonardo J.
    BLOOD, 2020, 136
  • [10] Initial Results of a Phase I Study of TNB-383B, a BCMA x CD3 Bispecific T-Cell Redirecting Antibody, in Relapsed/Refractory Multiple Myeloma
    Rodriguez, Cesar
    D'Souza, Anita
    Shah, Nina
    Voorhees, Peter M.
    Ben Buelow
    Vij, Ravi
    Kumar, Shaji K.
    BLOOD, 2020, 136
12345